News
HSIC
77.39
+1.10%
0.84
Weekly Report: what happened at HSIC last week (1208-1212)?
Weekly Report · 22h ago
Short bets on S&P 500 Healthcare sector rises to 2.12% in November; MRNA stays most shorted stock
Seeking Alpha · 3d ago
Did Henry Schein’s (HSIC) Expanded vVARDIS Deal Quietly Recast Its Minimally Invasive Dental Strategy?
Simply Wall St · 3d ago
Stock index futures, yields tread water with Fed decision in view
Seeking Alpha · 5d ago
Is Henry Schein’s Streamlined Distribution Strategy Creating Value at Around $74 a Share in 2025?
Simply Wall St · 5d ago
Henry Schein Initiated at Overweight by Barclays
Dow Jones · 6d ago
Henry Schein Price Target Announced at $86.00/Share by Barclays
Dow Jones · 6d ago
Barclays Initiates Coverage On Henry Schein with Overweight Rating, Announces Price Target of $86
Benzinga · 6d ago
Why Henry Schein (HSIC) Stock Is Up Today
Barchart · 6d ago
Henry Schein Extends Strategic Partnership with KKR
TipRanks · 6d ago
HENRY SCHEIN <HSIC.O>:  BARCLAYS INITIATES COVERAGE WITH OVERWEIGHT RATING AND TARGET PRICE $86
Reuters · 6d ago
Henry Schein initiated with an Overweight at Barclays
TipRanks · 12/08 21:22
Weekly Report: what happened at HSIC last week (1201-1205)?
Weekly Report · 12/08 10:15
Henry Schein Can Make Your Portfolio Smile
Seeking Alpha · 12/05 19:53
Henry Schein (HSIC): Revisiting Valuation After Expanded vVARDIS Distribution Deal in Preventive Dentistry
Simply Wall St · 12/05 19:24
How Investors May Respond To Henry Schein (HSIC) Gaining Exclusive U.S. Rights To Drill-Free Cavity Treatment
Simply Wall St · 12/04 06:19
HSIC Stock Benefits From Expanded Partnership With vVARDIS
NASDAQ · 12/02 13:25
Henry Schein expands exclusive distribution partnership with vVARDIS
TipRanks · 12/01 21:45
Henry Schein Secures Exclusive U.S. Distribution Rights for Curodont Repair Fluoride Plus
Reuters · 12/01 21:34
HENRY SCHEIN EXPANDS PARTNERSHIP WITH VVARDIS
Reuters · 12/01 21:34
More
Webull provides a variety of real-time HSIC stock news. You can receive the latest news about Henry Schein through multiple platforms. This information may help you make smarter investment decisions.
About HSIC
Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.